NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Joe Eaton Joe Eaton @JoeEaton.357811
Apr 28, 2023 Bullish $21.31 V 1
Feb 8, 2023 $9.75 -2.16% $9.56 V 98.06% 1
Feb 8, 2023 $9.83 -1.35% $9.56 V 97.22% 1
JS JS Pro
Nov 15, 2021 $6.11 +1.66% $6.15 X 99.35% 3
JS JS Pro
Nov 15, 2021 $6.15 +2.33% $6.15 X 100.00% 9
Nov 15, 2021 $7.00 +16.47% $6.15 V 86.18% 0
Aug 11, 2021 $5.88 -1.51% $5.97 X 98.49% 1
JS JS Pro
Aug 11, 2021 $5.85 -2.01% $5.97 X 97.99% 0
JS JS Pro
Dec 23, 2020 $6.29 +0.00% $6.29 X 100.00% 10
May 21, 2020 Bearish $7.89 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE